Table 1.

Baseline patient characteristics before transplantation, according to recipient IL28B genotype

	CC (n=56*)	CT (n=87*)	TT (n=28)	P-value*
Donor age, years	46 (26-56)	44 (28-60)	43 (25-55)	0.84
Age, years	51 (46-55)	48 (44-55)	50 (46-55)	0.44
Male gender (%)	36 (64)	61 (70)	19 (68)	0.77
HCV Genotype (%)				0.034
genotype 1	24 (65)	44 (73)	21 (91)
genotype 2	5 (14)	8 (13)	2 (9)
genotype 3	8 (22)	4 (7)	0 (0)
genotype 4	0 (0)	4 (7)	0 (0)
MELD¶	17 (13-22)	17 (13-21)	15 (12-19)	0.70
Prothrombin time, sec	13 (11-15)	14 (12-16)	13 (11-16)	0.82
Bilirubin, mg/dL	2.2 (1.4-4.0)	2.6 (1.,6-5.1)	3.2 (1.7-4.1)	0.46
Creatinine, mg/dL	1.0 (0.9-1.2)	1.0 (0.9-1.4)	1.1 (0.9-1.3)	0.89
Albumin, g/dL	3.1 (2.8-3.6)	3.1 (2.7-3.4)	2.9 (2.5-3.2)	0.048
Iothalamate clearance, mL/min	105 (84-117)	89 (62-107)	92 (64-119)	0.040

^§Continuous variables are expressed as medians (inter quartile range).

^¶MELD = Model for End-Stage Liver Disease

^#During first month after transplantation

^**Kruskall Wallis/Chi square